Q/C Technologies, Inc. (QCLS) Gross Margin
- Gross margin · 12 months: Value -37.18%; Formula and calculation Gross profit / revenue. Period ending 2020-06-30..
Gross margin
Overview →Financial period ending 2020-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | -37.18% | Gross profit / revenue. Period ending 2020-06-30. $-320.50K ÷ $862.03K × 100 ≈ -37.18% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | -320.50K USD | Gross Profit |
| Revenue | 862.03K USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 1.18M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2020-06-30 | $-320.50K | $862.03K | $1.18M | -37.18% |
| 2020-03-31 | $303.20K | $1.33M | $1.03M | 22.82% |
| 2019-12-31 | $478.75K | $1.58M | $1.10M | 30.36% |
| 2019-09-30 | $564.04K | $1.78M | $1.21M | 31.74% |
| 2019-06-30 | $509.37K | $1.91M | $1.40M | 26.62% |
| 2019-03-31 | $488.50K | $1.98M | $1.49M | 24.73% |
| 2018-12-31 | $127.28K | $1.67M | $1.54M | 7.64% |
| 2018-09-30 | $-285.13K | $2.32M | (m) | -12.26% |
| 2018-06-30 | $-13.47K | $2.44M | (m) | -0.55% |
| 2018-03-31 | $545.03K | $2.99M | (m) | 18.23% |
| 2017-12-31 | $2.51M | $3.93M | (m) | 63.86% |
| 2017-09-30 | $1.98M | $3.19M | (m) | 61.93% |
| 2017-06-30 | $2.00M | $3.13M | (m) | 63.94% |
| 2017-03-31 | $1.75M | $2.89M | (m) | 60.49% |
| 2016-12-31 | $1.88M | $2.96M | (m) | 63.42% |
| 2016-09-30 | $1.86M | $2.78M | (m) | 66.90% |
| 2016-06-30 | $1.47M | $2.33M | (m) | 63.12% |
| 2016-03-31 | $1.42M | $2.34M | (m) | 60.54% |
| 2015-12-31 | $1.16M | $2.12M | (m) | 55.05% |
| 2015-09-30 | $2.08M | $3.09M | (m) | 67.26% |
| 2015-06-30 | $2.38M | $3.38M | (m) | 70.48% |
| 2015-03-31 | $2.97M | $3.76M | (m) | 78.82% |
| 2014-12-31 | $3.25M | $4.43M | (m) | 73.45% |
| 2014-09-30 | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) |
| 2013-12-31 | $1.66M | $3.58M | (m) | 46.51% |
| 2013-09-30 | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |